Samsara BioCapital, L.P. - Mar 18, 2025 SCHEDULE 13D Report for KALARIS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (KLRS)

Filing Manager
Samsara BioCapital, L.P.
Reporting Manager
Samsara BioCapital, L.P.
Security
KALARIS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share
Symbol
KLRS
Shares outstanding
18.7M shares
Disclosed Ownership
11.4M shares
Ownership
61.2%
Form type
SCHEDULE 13D
Date filed
3/25/2025, 07:40 PM
Date of event
Mar 18, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Samsara BioCapital, L.P. 61.2% 11.4M 0 11.4M /s/ Srinivas Akkaraju By Samsara BioCapital GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member 0001699737
Samsara BioCapital GP, LLC 61.2% 11.4M 0 11.4M /s/ Srinivas Akkaraju By Srinivas Akkaraju, Managing Member 0001888829
Srinivas Akkaraju 61.2% 11.4M 0 11.4M /s/ Srinivas Akkaraju Srinivas Akkaraju 0001253170